/PRNewswire/ CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading lithium-ion battery manufacturer and electric energy.
/PRNewswire/ CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company"), announces a correction to its press release entitled "CBAK.
Message :
Required fields
DALIAN, China, March 15, 2021 /PRNewswire/ CBAK Energy Technology, Inc. (NASDAQ: CBAT) ( CBAK Energy, or the Company ), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it has signed a memorandum of cooperation (the Cooperation ) with a leading European hydrogen energy group with 100 years of operation history (the Hydrogen Energy Company ) to promote the development of hydrogen fuel cells.
As part of the Cooperation, both parties will be able to capitalize on each other s competitive advantages in technological innovation and industrial resources as well as exchange ideas on industry development. At the same time, both parties will be able to actively explore more opportunities to collaborate on high-quality projects going forward, including but not limited to such areas as hydrogen fuel cell production, hydrogen fuel cell stack, hydrogen transportation, hydrogen storage, hydrogen refueling sta
CBAK Energy Develops Special 26650 Battery for Ultra-low Temperature Application yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
CBAK Energy Technology, Inc. ("CBAK Energy," or the "Company," NASDAQ: CBAT), a leading lithium-ion battery manufacturer and electric energy solution provider, today announced that it closed a registered direct placement of approximately $70 million of its common stock, priced at the market under applicable Nasdaq rules with a price of $7.83 per share, and the concurrent private placement on February 10, 2021, as previously announced on February 8, 2021. The Company issued a total of 8,939,976 shares of common stock to certain institutional investors. The Company also issued Series A-1 Warrants to the investors to purchase a total of 4,469,988 shares of common stock and Series A-2 Warrants to purchase up to 2,234,992 shares of common stock, both of which were issued at an exercise price of $7.67 per share. Series A-1 Warrants and Series A-2 Warrants are exercisable for 42 months and 45 months, respectively, from the issue date. In addition, the Company issued Series